Abbott is recalling the Ellipse Implantable Cardioverter Defibrillators (ICDs) because electrical failures have been identified and determined to be due to a faulty manufacturing process, causing some aluminum wires to be partially exposed. ICDs which contain aluminum wires that are not fully insulated are prone to electrical shorting of the capacitor. The potential patient impact could be the inability to deliver high voltage therapy. There is currently no available method or procedure to determine which of these devices have this issue prior to failure.
Leads Implantable Devices
News and new technology innovations for leads implantable devices can be found on this channel.
-
-
Medtronic has received U.S. Food and Drug Administration (FDA) approval for the Attain Stability Quad MRI SureScan left heart lead. Paired with Medtronic quadripolar cardiac resynchronization therapy-defibrillators (CRT-D) and -pacemakers (CRT-P), the Attain Stability Quad lead is the only active-fixation left heart lead, according to the company, and is designed for precise lead placement and stability. The lead will be commercially available in the U.S. in summer 2019.
-
This is a virtual heart with the same electrophysiology characteristics as the real patient being developed to help optimize cardiac resynchronization therapy (CRT) lead placement. CRT currently has a ...
-
Interventional cardiac resynchronization therapy (I-CRT) describes the repurposing of a set of tools and techniques originally developed and employed by interventional cardiologists and radiologists ...
July 3, 2023 — Nearly one-third of patients with an implanted device to prevent sudden death have anxiety in the first ...
July 03, 2023
February 24, 2023 — Biotronik announced that it has received CE approval for the Selectra 3D implant tools to include ...
February 24, 2023
January 3, 2023 — The market has been studied for the below mentioned-segmentation and regional analysis for North ...
January 03, 2023
November 22, 2022 — CroíValve has announced the successful First in Human implants of its DUO Tricuspid Coaptation Valve ...
November 22, 2022
November 2, 2022 — For decades, left ventricular-assist devices (LVADs) have extended the lives of people whose hearts ...
November 02, 2022
August 5, 2022 — Black people and women with severe heart failure who might be good candidates for surgery to implant a ...
August 05, 2022
Feature | Heart Failure | By Jean-Luc Boulnois, Ph.D.
The current standard of care for heart failure (HF) is guideline-directed medical therapy combined with device-based ...
May 04, 2022
June 16, 2020 - Biotronik has today announced its commitment to giving physicians additional tools to pace in the His ...
June 16, 2020
September 20, 2019 — BioTrace Medical Inc. announced the company’s key activities at the 31st annual Transcatheter ...
September 20, 2019
August 5, 2019 — Abbott is recalling the Ellipse Implantable Cardioverter Defibrillators (ICDs) because electrical ...
August 05, 2019
May 13, 2019 — BioTrace Medical Inc. announced the company’s Tempo Lead has obtained CE Mark certification in Europe for ...
May 13, 2019
May 6, 2019 — Medtronic has received U.S. Food and Drug Administration (FDA) approval for the Attain Stability Quad MRI ...
May 06, 2019
This is a virtual heart with the same electrophysiology characteristics as the real patient being developed to help ...
February 27, 2019
Interventional cardiac resynchronization therapy (I-CRT) describes the repurposing of a set of tools and techniques ...
January 21, 2019
To extract or abandon broken or infected implantable, venous electrophysiology (EP) device leads has been a debate for ...
January 13, 2019© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now